Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

Phase III studies have demonstrated the efficacy of FOLFOXIRI regimens (5-fluorouracil/leucovorin, oxaliplatin, irinotecan) with/without bevacizumab in metastatic colorectal cancer (mCRC). Capecitabine is an orally administered fluoropyrimidine that may be used instead of 5-fluorouracil/leucovorin....

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbashi, Shouki, Aljubran, Ali, Alzahrani, Ahmad, Mohieldin, Ahmed, Soudy, Hussein, Shoukri, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618621/
https://www.ncbi.nlm.nih.gov/pubmed/26207614
http://dx.doi.org/10.1002/cam4.497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618621/
https://www.ncbi.nlm.nih.gov/pubmed/26207614
http://dx.doi.org/10.1002/cam4.497

Ejemplares similares